(Volume 3, Issue 5) e-Medical Dermatology Review:Psoriasis: Phototherapy in the Era of Biologic Agents

eMedical Dermatology Review is a monthly CE series for the Dermatology nurse and health care professional. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

(Volume 3, Issue 5)

 

Target Audience

Dermatology nurses and health care professionals

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

 

  • Describe the evolving trends in treatment combinations with light therapy plus biologics, using narrowband ultraviolet B (NB-UVB) phototherapy and etanercept as a model.

  • Discuss emerging safety and financial issues regarding the use of phototherapy and/or biologics for the treatment of psoriasis.

  • Articulate the real-world efficacy of psoralen plus ultraviolet A (PUVA) therapy vs biologic agents for the treatment of psoriasis.

 

 

Additional information
Contact email: 
ijhn@jhmi.edu
Course summary
Available credit: 
  • 1.00 ANCC
Registration opens: 
02/20/2012
Registration closes: 
02/19/2014
Cost:
$0.00
Elisabeth G. Richard, MD
Assistant Professor of Dermatology
The Johns Hopkins University School of Medicine
Baltimore, Maryland
 
Warwick L. Morison, MD
Professor of Dermatology
The Johns Hopkins University School of Medicine
Baltimore, Maryland
 

Available Credit

  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.